Rojkjaer Lisa
- SEC CIK
- 0001846460
No open-market purchases or sales filed in the past year.
Current role at each company
- RIGL Rigel Pharmaceuticals IncEVP, Chief Medical Officeras of Jun 22, 2026
- VIRX Viracta Therapeutics, Inc.Chief Medical Officeras of Mar 17, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rojkjaer Lisa as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VIRX Viracta Therapeutics, Inc.
Chief Medical Officer6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2023 (view filing) | Feb 27 | 1 day | Rojkjaer LisaChief Medical Officer | SSale | −2.16K | $1.68 | −$3.62K | −4.3%48.1K after | |
| Nov 29, 2022 (view filing) | Nov 28 | 1 day | Rojkjaer LisaChief Medical Officer | SSale | −2.12K | $2.72 | −$5.76K | −4.4%46.1K after | |
| Aug 29, 2022 (view filing) | Aug 26 | 3 days | Rojkjaer LisaChief Medical Officer | SSale | −2.19K | $4.01 | −$8.78K | −4.7%44.1K after | |
| May 27, 2022 (view filing) | May 26 | 1 day | Rojkjaer LisaChief Medical Officer | SSale | −2.15K | $1.90 | −$4.09K | −4.9%42.2K after | |
| Mar 1, 2022 (view filing) | Feb 28 | 1 day | Rojkjaer LisaChief Medical Officer | SSale | −2.40K | $2.78 | −$6.66K | −5.6%40.2K after | |
| Nov 29, 2021 (view filing) | Nov 26-29 | 3 days | Rojkjaer LisaChief Medical Officer | SSale | −4.54K | $4.81 | −$21.8K | −10.6%38.5K after | 2 lots |